These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 1711914)

  • 21. Effect of the 5-hydroxytryptamine3 receptor antagonist itasetron (DAU 6215) on (+)-N-allylnormetazocine-induced dopamine release in the nucleus accumbens and in the corpus striatum of the rat: an in vivo microdialysis study.
    Volonté M; Ceci A; Borsini F
    J Pharmacol Exp Ther; 1995 Oct; 275(1):358-67. PubMed ID: 7562571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tianeptine increases the extracellular concentrations of dopamine in the nucleus accumbens by a serotonin-independent mechanism.
    Invernizzi R; Pozzi L; Garattini S; Samanin R
    Neuropharmacology; 1992 Mar; 31(3):221-7. PubMed ID: 1630590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B; Domeney AM; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for 5-HT4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rat.
    Bonhomme N; De Deurwaèrdere P; Le Moal M; Spampinato U
    Neuropharmacology; 1995 Mar; 34(3):269-79. PubMed ID: 7543190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat.
    Hagan RM; Jones BJ; Jordan CC; Tyers MB
    Br J Pharmacol; 1990 Feb; 99(2):227-32. PubMed ID: 1691672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine releasing effect of phenylbiguanide in rat striatal slices.
    Benuck M; Reith ME
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jun; 345(6):666-72. PubMed ID: 1635590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of accumbens 5-HT3 receptor down-regulation by ondansetron administered during continuous cocaine administration.
    King GR; Xiong Z; Ellinwood EH
    Eur J Pharmacol; 1999 Jan; 364(2-3):79-87. PubMed ID: 9932709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoxetine increases the extracellular levels of serotonin in the nucleus accumbens.
    Guan XM; McBride WJ
    Brain Res Bull; 1988 Jul; 21(1):43-6. PubMed ID: 2464422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of stereoisomers of zacopride to analyze actions of 5-hydroxytryptamine on enteric neurons.
    Wade PR; Mawe GM; Branchek TA; Gershon MD
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G80-90. PubMed ID: 1987811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens.
    Damsma G; Day J; Fibiger HC
    Eur J Pharmacol; 1989 Sep; 168(3):363-8. PubMed ID: 2479574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-HT3 receptor agonist induced carrier-mediated release of dopamine in rat striatum in vivo.
    Santiago M; Machado A; Cano J
    Br J Pharmacol; 1995 Sep; 116(1):1545-50. PubMed ID: 8564217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of repeated daily treatments with a 5-HT3 receptor antagonist on dopamine neurotransmission and functional activity of 5-HT3 receptors within the nucleus accumbens of Wistar rats.
    Liu W; Thielen RJ; McBride WJ
    Pharmacol Biochem Behav; 2006 Jun; 84(2):370-7. PubMed ID: 16828150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central action of 5-HT3 receptor ligands in the regulation of sleep-wakefulness and raphe neuronal activity in the rat.
    Adrien J; Tissier MH; Lanfumey L; Haj-Dahmane S; Jolas T; Franc B; Hamon M
    Neuropharmacology; 1992 Jun; 31(6):519-29. PubMed ID: 1407392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine release in the nucleus accumbens and latent inhibition in the rat following microinjections of a 5-HT1B agonist into the dorsal subiculum: implications for schizophrenia.
    Boulenguez P; Peters SL; Mitchell SN; Chauveau J; Gray JA; Joseph MH
    J Psychopharmacol; 1998; 12(3):258-67. PubMed ID: 10958252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis.
    Parsons LH; Justice JB
    Brain Res; 1993 Mar; 606(2):195-9. PubMed ID: 8490716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5-HT release in the frontal cortex of freely-moving rats.
    Cheng CH; Costall B; Ge J; Naylor RJ
    Br J Pharmacol; 1993 Nov; 110(3):1079-84. PubMed ID: 7507776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baroreceptor reflex inhibition induced by the stimulation of serotonin3 receptors in the nucleus tractus solitarius of the rat.
    Merahi N; Orer HS; Laporte AM; Gozlan H; Hamon M; Laguzzi R
    Neuroscience; 1992; 46(1):91-100. PubMed ID: 1350667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The differential activities of R (+)- and S(-)-zacopride as 5-HT3 receptor antagonists.
    Barnes JM; Barnes NM; Costall B; Domeney AM; Johnson DN; Kelly ME; Munson HR; Naylor RJ; Young R
    Pharmacol Biochem Behav; 1990 Dec; 37(4):717-27. PubMed ID: 2128757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased dopamine and serotonin metabolism in rat nucleus accumbens produced by intracranial self-stimulation of medial forebrain bundle as measured by in vivo microdialysis.
    Nakahara D; Ozaki N; Miura Y; Miura H; Nagatsu T
    Brain Res; 1989 Aug; 495(1):178-81. PubMed ID: 2476201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-(S)-zacopride and [3H]granisetron.
    Barnes JM; Barnes NM
    Biochem Pharmacol; 1993 May; 45(10):2155-8. PubMed ID: 8390263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.